Acorah Software Products - Accounts Production16.0.110falsetruefalsetrueNo description of principal activity27 February 202431 October 202431 October 202415525931Mr A S Sandhuiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure155259312024-02-26155259312024-10-31155259312024-02-272024-10-3115525931frs-core:CurrentFinancialInstruments2024-10-3115525931frs-bus:PrivateLimitedCompanyLtd2024-02-272024-10-3115525931frs-bus:FilletedAccounts2024-02-272024-10-3115525931frs-bus:Micro-entities2024-02-272024-10-3115525931frs-bus:AuditExempt-NoAccountantsReport2024-02-272024-10-3115525931frs-bus:Director12024-02-272024-10-31
Registered number: 15525931
BioLink Intelligence LTD
Financial Statements
For the Period 27 February 2024 to 31 October 2024
BioLink Intelligence LTD
Balance Sheet
As At 31 October 2024
Balance Sheet
Registered number: 15525931
31 October 2024
£
Current assets
3,421
Creditors: Amounts Falling Due Within One Year
(3,350)
NET CURRENT ASSETS
71
TOTAL ASSETS LESS CURRENT LIABILITIES
71
NET ASSETS
71
CAPITAL AND RESERVES
71
Notes
1.General Information
BioLink Intelligence LTD is a private company, limited by shares, incorporated in England & Wales, registered number 15525931. The registered office is 195 Princes Gardens, London, W3 0LT.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.